Aiming to export 2 MTPA of green fuels,this partnership positions India as a leader in global decarbonization efforts.
01-15
SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch
01-15
Boudewijn Pesch Joins Verkada as Vice President of JAPAC Channel Sales SAN MATEO,Calif.,Jan. 15,2025-- Verkada,a leader in cloud-based physical security,today announced the appointment of Boudewijn P
01-15
NEW YORK,Jan. 15,2025-- Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company"),a leading provider of OTC pharmaceutical cross-border e-commerce
01-15
A new study byMoneySmart finds that over half (52%) of adults living in Hong Kong SAR and Singapore now turn to social media as their primary source of financial advice,with YouTube emerging as the mo
01-15
SINGAPORE,Jan. 13,2025--KONE Corporation,a global leader in the elevator and escalator industry,has won an order to provide a suite of People Flow® solutions for the Peninsula Integrated Resort b
01-14
Study examines the untapped potential of workers in the first of a series of studies comprising the refreshed "People at Work 2025" report,built on the ADP Research Global Workforce Survey
01-14
MELBOURNE,Australiaand INDIANAPOLIS,Jan. 14,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today advises that Dr. Christian Behrenbruch,Managing Director and Group CEO,
01-14
TOKYO,Jan. 14,2025-- Petnow Inc.,a pioneering pet tech company,is expanding its footprint in Japan following the app\'s release in October 2024. Strengthening its presence,Petnow recently received nat
01-14
PORT VILA,Vanuatu,Jan. 13,2025--Vantage Markets,a leader in online trading solutions,has expanded its popular Deposit Bonus promotion to include Copy Trading Accounts,enhancing opportunities for Sign
01-14
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
